Omeprazole Aurobindo (Omeprazole)

Omeprazole inhibits the H+/K+‑ATPase enzyme, also known as the gastric proton pump, located on the secretory surface of parietal cells. This irreversible blockade stops the final step of acid secretion, leading to a sustained increase in gastric pH and allowing ulcerated or inflamed tissue to recover.

The appropriate dose of Omeprazole Aurobindo is determined by the prescribing healthcare professional based on the specific indication, patient age, renal function, and treatment duration. Dosage regimens may vary, and patients should follow the prescriber’s instructions without self‑adjusting the amount.

Omeprazole is classified as pregnancy category B in many jurisdictions, indicating no evidence of risk in animal studies but limited human data. It should be used during pregnancy or lactation only if clearly needed and after a risk‑benefit assessment by the prescriber. Breastfeeding mothers should consult their doctor.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Omeprazole belongs to the same class as esomeprazole, lansoprazole, pantoprazole, and rabeprazole. All share a similar mechanism of inhibiting the gastric proton pump, but they differ in pharmacokinetic profiles, potency, and drug‑interaction potential. Choice of agent often depends on physician preference, patient response, and specific drug‑interaction considerations.

Omeprazole Aurobindo tablets should be stored at temperatures below 25 °C, in the original packaging to protect from moisture and light. Keep the product out of reach of children and avoid storing in humid environments such as bathrooms.

Omeprazole Aurobindo is taken orally, usually as a whole tablet swallowed with a glass of water. It is generally recommended to take the dose before a meal, often in the morning, unless the prescriber advises a different schedule based on the therapeutic goal.

Serious risks, though uncommon, include severe allergic reactions (anaphylaxis), Clostridioides difficile‑associated diarrhea, low magnesium levels, liver enzyme elevations, and rare skin conditions such as Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience rash, persistent diarrhea, muscle cramps, or signs of liver dysfunction.

Omeprazole Aurobindo is contraindicated in individuals with known hypersensitivity to omeprazole or any component of the formulation. Caution is advised for patients with severe liver disease, those taking medications that require an acidic environment for absorption, and patients with certain genetic metabolic disorders. The prescriber will assess suitability.